Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Other
Abdominal pain
(2003): Cramer JA+, Epilepsy Res 56(2–3), 135
Cough
(2006): Glauser TA+, Neurology 66(11), 1654
Death
(2006): Skopp G+, Arch Kriminol 217(5-6), 161 (with
carbamazepine )
Hepatotoxicity
(2006): Skopp G+, Arch Kriminol 217(5-6), 161 (with
carbamazepine )
Inappropriate secretion of antidiuretic hormone (SIADH)
(2005): Nasrallah K+, Epilepsia 46(6), 972
Infections (sic) (13–26%)
(2003): Ben-Menachem E+, Epilepsy Res 53(1), 57 (26.6%)
(2002): Boon P+, Epilepsy Res 48(1), 77
(2002): Glauser TA+, Epilepsia 43(5), 518
(2001): Nash EM+, Am J Health Syst Pharm 58(13), 1195
(2000): Cereghino JJ+, Neurology 55, 236
Neurotoxicity
(2005): Kapoor P+, Electromyogr Clin Neurophysiol 45(1), 15
Pain
(2002): Boon P+, Epilepsy Res 48(1), 77
LEVOBETAXOLOL
Trade names: Betaxon (Alcon); L-betaxolol
Indications: Chronic open-angle glaucoma, ocular hypertension
Category: Adrenergic beta-receptor antagonist
Half-life: 20 hours
Reactions
Skin
Dermatitis (